an innovative start-up that is transforming the pharmaceutical industry by enabling pharmacies to manufacture personalised medicines using 3D printing
an innovative start-up that is transforming the pharmaceutical industry by enabling pharmacies to manufacture personalised medicines using 3D printing
Sirius NeoSight is an innovative disruptive technology company for the detection of sub-clinical neo-cancers, relapses and the therapeutic follow-up of patients.
HuntX Pharma is developing small oral molecules to prevent the onset of genetic neurodegenerative diseases.
Kimialys offers an innovative, patented chemical coating that improves the reliability of diagnostic tests.
Odimma develops personalized immunotherapy using AI and synthetic DNA technology.
Abcely develops innovative medical and pharmaceutical technologies for the treatment of mucosal cancers.
Alga Therpeutics produces cancer-fighting antibodies from micro-algae.
A new generation of digital solutions for pain management throughout the patient journey.
Hephaistos-Pharma is developing a new generation of immunostimulant to treat metastatic and hardly accessible tumors
Healshape is developing a personalized, natural, regenerative and resorbable bioprosthesis for women who have undergone a mastectomy following breast cancer.
Genexpath produces and markets cancer characterization kits combined with results analysis software.
Wheeleo is developing an innovative walking aid solution for greater independence and reduced risk of falls.
"We believe that when it comes to seed financing in the healthcare sector, an innovative start-up can effectively benefit from the support of such a specialized investor, as they understand the specificity of our business model much better than generalist business angels or family office and they are more flexible than life science VCs."
"Angels Santé, in addition to other investors, has given Abcely credibility for its project in the eyes of other, more generalist co-investors, less able to appreciate the real challenges that can be encountered by a biotech company in the healthcare field, more specifically in oncology."
"Angel Santé gives you access to a network of professional investors in the healthcare sector who are keen to get involved in your company's development. Beyond financing, you gain access to invaluable skills in a sector of expertise."
The club offers quarterly physical meetings, co-hosted by entrepreneurs themselves. You benefit from their feedback on a specific theme.
Sessions are co-hosted by other speakers (associate corporate members, ecosystem players, etc.) sharing their expertise.
ANGELS SANTE
24-30 Boulevard Pasteur – Villa M – 75015 Paris
